USFDA approves Pfizer’s Hympavzi for rare bleeding disorder hemophilia | World News
Analysts expect sales of Hympavzi to reach $300 million by 2030, according to estimates compiled by LSEG. (Photo: Reuters)2 min ...
Read more- Latest
ADVERTISEMENT
Analysts expect sales of Hympavzi to reach $300 million by 2030, according to estimates compiled by LSEG. (Photo: Reuters)2 min ...
Read more
LocalTak is your premier news and media platform, dedicated to delivering timely, accurate, and comprehensive news coverage. Stay connected with the latest updates, insightful analysis, and in-depth reporting on a wide range of topics. Trust LocalTak to keep you informed and ahead in an ever-changing world.
